Our leadership, including the management team and Board of Directors, is made up of venture capital investing,  AI technology, biotechnology and pharmaceutical industry experts who are recognized for their contributions to discovering and developing new therapies and their track record of successfully bringing creating and managing AI-Enabled drug discovery startups.  

Greg Getten

Co-Founder, Chairman

Hentabli Hamza PhD

Co-Founder, Chief Technology Officer

Sehrish Naz, PhD

Chief Operating Officer

Henry Yu, PhD

General Manger – Asia Pacific

Board Members & Advisors

Pamela Garzone, PhD

Board Member

Daniel Kwong

Board Advisor

Girinath Pillai, PhD

Board Advisor

Rick Sayegh, MD, MBA

Medical Advisor

Raymond Choo, PhD

Technical Advisor

Henok G. Woldu, PhD

Technical Advisor